Repligen
RGEN
#2109
Rank
NZ$15.40 B
Marketcap
NZ$273.72
Share price
0.51%
Change (1 day)
4.36%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): NZ$42.04 Million

According to Repligen 's latest financial reports the company's current earnings are NZ$0.70 Billion. In 2024 the company made an earning of -NZ$10.95 Million a decrease over its 2023 earnings that were of NZ$84.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$42.04 M-484.3%
2024 -NZ$10.95 Million-113.01%
2023 NZ$84.08 M-78.01%
2022 NZ$0.38 B33.37%
2021 NZ$0.28 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$61.51 M25.93%
2018 NZ$48.84 M105.61%
2017 NZ$23.75 M-11.46%
2016 NZ$26.83 M14.91%
2015 NZ$23.35 M20.26%
2014 NZ$19.41 M-51.49%
2013 NZ$40.02 M90.98%
2012 NZ$20.95 M
2010 NZ$0.3 M-103.81%
2009 -NZ$7.97 Million-223.84%
2008 NZ$6.42 M
2006 -NZ$4.32 Million229.64%
2005 -NZ$1.32 Million-89.16%
2004 -NZ$12.09 Million-16.86%
2003 -NZ$14.54 Million88.72%
2002 -NZ$7.71 Million-27.88%
2001 -NZ$10.69 Million-1.74%
2000 -NZ$10.88 Million85.93%
1999 -NZ$5.85 Million159.16%
1998 -NZ$2.26 Million85.71%
1997 -NZ$1.22 Million-70.83%
1996 -NZ$4.17 Million-72.41%
1995 -NZ$15.1 Million-60.63%
1994 -NZ$38.36 Million45.39%
1993 -NZ$26.38 Million39.45%
1992 -NZ$18.92 Million-32.3%
1991 -NZ$27.95 Million6.62%
1990 -NZ$26.21 Million1577.78%
1989 -NZ$1.57 Million-57.14%
1988 -NZ$3.65 Million-362.5%
1987 NZ$1.38 M-130.77%
1986 -NZ$4.52 Million136.36%
1985 -NZ$1.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
NZ$0.65 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.17 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.01 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$17.80 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$12.31 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.94 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.56 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.20 B 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$38.52 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA